Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Directors of Sequenom inflated share price with false and misleading statements about its genetic diagnostic test, SEQureDx, shareholders claim in San Diego Federal Court.

Shareholders challenge HLTH Corp.'s $1.2 billion merger with WebMD Health Corp., in New York County Court.

Shareholders say directors of FiberNet Telecom Group are selling the company too cheaply to the Zayo Group - for $11.45 a share, or $88 million - though RCN Corp. offered $12.50 a share, in Delaware Chancery Court.

Shareholders claims CuraGen is selling itself too cheaply to Celldex Therapeutics, for $94.5 million, o4 $1.55 a share, in New Haven Superior Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...